Rosetta

Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting

...bestos exposure, from other carcinomas in the lung and pleura. The Company acquired exclusive U.S. rights to the three tests from rosetta Genomics in April 2009. About Prometheus Prometheus Laboratories Inc. is a specialty pharmaceutical and diagnostic company committed to de...

Gene Network Sciences Names Departing Merck Head of Genetics Eric Schadt as Co-Chair of Scientific Advisory Board

...istributed data platform designed to enable collaboration by integrating the myriad of genomic data sets in the public and private domains. At Merck's rosetta subsidiary, Dr. Schadt founded the Genetics department. His work at Merck focused on elucidating the genetic circuitry of common human diseases such a...

Cambridge Healthtech Institute's 7th Annual Bio-IT World Conference & Expo Enabling Technology - Leveraging Data - Transforming Medicine

...eam, Inc.; Clifford Reid, Ph.D., Chief Executive Officer, Complete Genomics, Inc.; and Eric E. Schadt, Ph.D., Executive Scientific Director, Genetics, rosetta Inpharmatics/Merck Research Labs. A plenary panel discussion on the exciting field of "personal genomics" will be held. Bio-IT World m...

Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference

..., New Jersey, November 5 /PRNewswire-FirstCall/ -- rosetta Genomics Ltd. (Nasdaq: ROSG ), a leader in the dev...vel diagnostic strategy for many diseases. About rosetta Genomics rosetta Genomics (Nasdaq: ROSG ) is a leader in the field...

LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients

...med mesothelioma blog readers of a new scientific test that may offer early diagnosis of mesothelioma cancer. The diagnostic test is an effort between rosetta Genomics Ltd. and the Columbia University Medical Center. The two organizations have completed the test that can determine between two similar forms o...

NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO

... microRNA expression in pleural mesothelioma: Implications for early detection and prognostication. Researchers from NYU Langone Medical Center and rosetta Genomics Ltd. present evidence from a study that used microRNAs (mirs) to discover potentially novel biomarkers for mesothelioma. Mirs are non-coding ...

Computer game's high score could earn the Nobel Prize in medicine

... often fail. "People, using their intuition, might be able to home in on the right answer much more quickly." Rosetta@home and Foldit both use the rosetta protein-folding software. Foldit is the first protein-folding project that asks volunteers for something other than unused processor cycles on their c...

New genetic techniques to combat lung cancer

...port (Abstract No. 81O; Friday 25th April, 16:30), Israeli researchers from rosetta Genomics (Nasdaq:ROSG), a biotech company developing microRNA-based technol...y be used as important treatment guide," said Dr. Maya Gottfried, member of rosetta Genomics Medical Advisory Board and head of the Lung Cancer Unit at Meir Me...

Life Sciences Fund grants awards to launch health research

... competitiveness and fuel the growth of related biotechnology companies. Organizations collaborating in this research are: Group Health Cooperative, rosetta Inpharmatics LLC, and Children's Hospital & Regional Medical Center. Patricia Kuhl, University of Washington, $4,033,304 Program title: Early ...

Keynoters, symposia, workshops highlight dental research meeting

... Manuscript a JDR Perspective Thursday, April 3, 9:45 a.m. 11:15 a.m., rosetta Room (Sponsor: Journal of Dental Research) HOW #3: Oral Pathogen ...e Analysis and Comparative Study Friday, April 4, 9:45 a.m. 11:15 a.m., rosetta Room (Sponsor: NIDCR) ...

Rosetta in Medical Technology

Prometheus and Rosetta Genomics Announce License and Collaboration Agreement

MicroRNA-based Molecular Diagnostics to Mark Prometheus' Entry into Oncology Market; Rosetta to Receive Milestones and Research and Development Funding plus Future Royalties SAN DIEGO, PHILADELPHIA and REHOVOT, Israel, April 13 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmac...

Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay

The Study Will Compare the Results of Rosetta Genomics' microRNA-based Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous non Small Cell Lung Cancer, With Current Diagnostic Methods A Test Based on the miRview(TM) Technology First Approved for Clinical use Thro...

MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma

REHOVOT, Israel and JERSEY CITY, New Jersey, September 18 /PRNewswire-FirstCall/ -- - A Collaborative Study by Scientists at the Weizmann Institute of Science and Scientists at Sheba Medical Center, With the aid of Rosetta Genomics, Demonstrated That Overexpression of miR-451 Inhibited Growth ...

M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases

The Study Will Correlate the Results of Rosetta Genomics' MicroRNA-Based CUP Assay With Diagnostic Work Conducted at M.D. Anderson Cancer Center Data on the Company's MicroRNA-Based CUP Assay and its High Sensitivity and Accuracy was Recently Published in the April Issue of Nature Biotechnolo...

First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval

Test Developed and Validated by Columbia University Medical Center Based on Rosetta Genomics' Proprietary MicroRNA Technology The Test Differentiates Squamous From Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous-Cell Carcinoma of the Lung With Sensitivity...

Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica

The Laboratory-Developed Test is Designed to Differentiate Squamous From Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous Cell Carcinoma of the Lung With Sensitivity of 96 Percent and Specificity of 90 Percent. Accurate Diagnosis is Importa...

Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

...Bayer HealthCare Pharmaceuticals Inc. About rosetta Genomics rosetta Genomics (Nasdaq: ROSG ) is a leading developer ...IP position and proprietary platform technologies, rosetta Genomics is working on the application of these te...

Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests

...HILADELPHIA, December 11 /PRNewswire-FirstCall/ -- rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer ...us. The test is now commercially available through rosetta Genomics CLIA-certified lab in Philadelphia. ...microRNA-based test, is a landmark event for us at rosetta Genomics," said Amir Avniel, President and CEO of...

Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum

... Indications Using This Proprietary Technology, rosetta Genomics is Currently Developing a B... New Jersey, September 5 /PRNewswire-FirstCall/ -- rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the deve...noted Dr. Dalia Cohen, Chief Scientific Officer of rosetta Genomics. "The results of this study are the basis...

Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain

...CITY, New Jersey, July 9 /PRNewswire-FirstCall/ -- rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the deve...ofiles for characterization of brain malignancies. rosetta Genomics' scientists measured microRNA expression ...vel diagnostic strategy for many diseases. About rosetta Genomics ...

Rosetta in Biological News

UW's Rosetta software to unlock secrets of many human proteins

University of Washington TechTransfer recently licensed software that will give scientists a huge advantage in the fight against disease. The software, known as Rosetta, predicts how proteins fold, information that is highly valuable to biological and biomedical researchers. UW Tech Transfer's Digi...

Finding the constant in bacterial communication

... DURHAM, N.C. The rosetta Stone of bacterial communication may have been found. Although they have no sensory organs, bacteria can get a good idea about what's going on in t...

Protein folding researcher David Baker to receive Sackler Prize in Biophysics

...nd out of the cell, and that are responsible for the passage of neural impulses and communication between cells. The Baker group was able to apply the rosetta program to these unusual proteins by treating the membranes as a series of layers with different protein folding requirements. Baker has involved p...

Scripps research team sheds light on immune system suppression

...ofessor at the University of California, San Diego, worked with mice infected with lymphocytic choriomeningitis virus, a model Oldstone describes as a rosetta Stone for understanding viral pathogenesis and immune system recognition of foreign substances like microbes and viruses. The researchers found that t...

Details of evolutionary transition from fish to land animals revealed

... to limbs) but also to the internal head skeleton. "Exquisite specimens of Tiktaalik roseae discovered several years ago continue to function as rosetta stones for understanding the emergence of quadripeds on land," said H. Richard Lane, program director in the National Science Foundation (NSF)'s Divis...

CSHL team traces extensive networks regulating alternative RNA splicing

...view. In a paper appearing this week in the journal Genes & Development , Drs. Zhang, Krainer, and colleagues from CSHL, Stony Brook University, and rosetta Inpharmatics, reveal how two closely related proteins called Fox-1 and Fox-2--which are two among many splicing factors--control regulatory networks i...

American Chemical Society's Weekly PressPac -- Dec. 5, 2007

...ONTACT: Ho-Young Kim, Ph.D. Seoul National University Seoul, Korea Email: hyk@snu.ac.kr ARTICLE #3 FOR IMMEDIATE RELEASE Toward a rosetta Stone for Microbes Secret Language ACS Chemical Biology Scientists are on the verge of decoding the special chemical language that bacteria use ...

Duke scientists map imprinted genes in human genome

...ughout the human genome, and they say a modern-day rosetta stone a form of artificial intelligence called ma...to an algorithm, which was able like the original rosetta stone to decode seemingly impenetrable data, in t...everal dozen had been identified. Using their new rosetta stone, however, Jirtle and Hartemink found 156 new...

Powerful integration of lipid metabolic profiling with gene expression analysis

...ntly published research article in the Journal of Proteome Research, authored by researchers from the Nestl Reserarch Center, Genomatix Software GmbH, rosetta Inpharmatics LLC, CXR Biosciences Ltd, the Cancer Research UK Molecular Pharmacology Unit demonstrates the synergisms and enhanced analytic power of t...

American Chemical Society's Weekly PressPac -- Oct. 24, 2007

...outh Plymouth, United Kingdom Phone: +44 1752 232966 E-mail: emma.teuten@plymouth.ac.uk ARTICLE #2 FOR IMMEDIATE RELEASE A rosetta Stone for traditional Chinese medicine Journal of Chemical Information and Modeling Scientists in the United Kingdom have "decoded" the inscr...

Rosetta in Biological Technology

Microsoft Signs Agreement With Merck & Co. Inc. to Acquire Assets of Rosetta Biosoftware, Strengthening Position in Life Sciences Industry

Multifaceted agreement enhances Microsoft Amalga Life Sciences to accelerate basic research and drive personalized medicine. REDMOND, Wash., June 1 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of ...

/C O R R E C T I O N -- Rosetta Genomics Ltd/

In the news release, "Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference" issued on 5 Nov 2008 13:30 GMT, by Rosetta Genomics Ltd nasdaq:ROSG over PR Newswire, we are advised by a representative of the company that new webcast information has been added below the...

Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics

REHOVOT, Israel and JERSEY CITY, New Jersey, October 27 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG ), a leader in the development of microRNA-based diagnostics and therapeutics, today announced that Credit Suisse, as part of a settlement agreement it has reached with the Att...

/C O R R E C T I O N -- Rosetta Genomics Ltd/

In the news release, "Rosetta Genomics Reports First Quarter 2008 Financial Results" issued on 21 May 2008 12:30 GMT, by Rosetta Genomics Ltd nasdaq:ROSG over PR Newswire, we are advised by a representative of the company that the time of the conference call, as stated beneath the header 'Conf...

Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics' Scientists and Collaborators in Nature Biotechnology

A Published Study Shows the Potential of microRNAs to be Used as Biomarkers for Diagnosing the Primary Tumor Site in Patients With Cancer of Unknown Primary (CUP) Rosetta Genomics is Currently Developing a Technology That Will be the Basis of a CUP Diagnostic Test...

Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer

The American Cancer Society Estimates Approximately 20,000 Patients are Diagnosed With Brain Cancer Each Year in the U.S. REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, January 14 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG ), a leader in the development of micr...

NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma

Program Seeks to Identify microRNA Biomarkers for Overall Survival and Risk of Melanoma Metastasizing to Distant Sites REHOVOT, Israel and NEW YORK, September 7 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG ), a global leader in the field of microRNA and RNAi, ann...

Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"

..., April 28, Eric E. Schadt, Ph.D., Executive Scientific Director, Genetics, rosetta Inpharmatics/Merck Research Labs and Sage, discusses the latest advances in... session features speakers from Harvard Medical School; Cambridge Computer; rosetta Inpharmatics; Genetech; Johnson & Johnson; Eli Lilly; Pfizer; National ...

Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Identified Candidate MicroRNA Biomarkers in Serum

...HOVOT Israel, January 16 /PRNewswire-FirstCall/ -- rosetta Genomics Ltd. (Nasdaq: ROSG ) and collaborators, ...n Francisco. "The initial data presented by rosetta is very significant" said Aaron Ciechanover, Nobel...r. Ayelet Chajut, EVP R&D Molecular Biology at rosetta and the primary investigator of the study.[2] "We ...

Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.

...Y, New Jersey, January 8 /PRNewswire-FirstCall/ -- rosetta Genomics, Ltd. (NASDQ: ROSG), the leading develope...sed. "This is yet another important step in rosetta Genomics' commercialization efforts," noted Ronen Tamir, Chief Commercialization Officer at rosetta Genomics. "As Israel provided its citizens with he...